Despite the stigma, the coca plant is effectively entering the drug reform movement as part of an expected “third wave of decriminalization” along with other controlled substances including ...

This article is authored by Hari Kiran Chereddi, managing director & CEO, HRV Pharma.

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges. With a market value exceeding $280 ...

The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...

Taking place from July 8-10 at the Queen Sirikit National Convention Centre (QSNCC) in Bangkok, Thailand, the event is expected to welcome more than 10,000 trade visitors from over 70 countries and ...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearly 65% of APIs and intermediates sourced from there. NITI ...

Pharmaceutical companies are facing increasing pressure to update their supply chains. For some, it's going to be an uphill battle. A new report from PwC US concludes that many pharmaceutical supply ...

Telangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an ...

MONTRÉAL, Jan. 22, 2024 /PRNewswire/ - CGI (NYSE: GIB) (TSX: GIB.A), one of the largest business and IT consulting companies in the world, today announced a partnership with Körber aimed at enabling ...

The pharmaceutical supply chain has entered a new era—one defined not just by compliance and safety, but by digital agility, operational efficiency, and data-driven decision-making. According to ...

The Wall Street Journal called the IPO the hottest of this year. No, it wasn’t a new artificial intelligence stock or social media site. It was for a company most people have never heard of, but that ...

If you’re looking to get a glimpse into the future of technology for managing the pharmaceutical cold chain, pay attention to where investors are placing their bets. And not the generalist investor ...